ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Monday, March 16, 2015

Submitted by

Mark Ferguson

Source

Source Name: JAMA

Source URL: http://jama.jamanetwork.com/article.aspx?articleID=2190986&utm_source=Silverchai…

Author(s)

David R. Holmes Jr; J. Matthew Brennan; John S. Rumsfeld; David Dai; Sean M. O’Brien; Sreekanth Vemulapalli; Fred H. Edwards; John Carroll; David Shahian; Fred Grover; E. Murat Tuzcu; Eric D. Peterson; Ralph G. Brindis; Michael J. Mack; for the STS/ACC TVT Registry

Using STS/ACC registry data, the authors updated 30-day outcomes and present 1 year outcomes for TAVR pts. Over 12,000 pts were in the registry; median age was 84, and STS predicted operative mortality risk was 7.1%. 30-day mortality was 7.0%, 1-year mortality was 23.7%. 1-year mortality was associated with advanced age, male sex, end-stage renal disease, COPD, non-transfemoral access, high predicted risk, and preoperative afib.